AstraZeneca plc (ADR)
General ticker "AZN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $207.0B
AstraZeneca plc (ADR) follows the US Stock Market performance with the rate: 19.1%.
Estimated limits based on current volatility of 1.3%: low 64.39$, high 66.10$
Factors to consider:
- Company pays dividends: last record date 2024-08-09, amount 0.49$ (Y2.94%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [50.78$, 74.76$]
- 2024-12-30 to 2025-12-30 estimated range: [50.63$, 75.67$]
Financial Metrics affecting the AZN estimates:
- Positive: Non-GAAP EPS, $ of 3.64 > 2.29
- Positive: 9.05 < Operating profit margin, % of 17.88
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 5.56
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
Short-term AZN quotes
Long-term AZN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $37,417.00MM | $44,351.00MM | $45,811.00MM |
| Operating Expenses | $36,361.00MM | $40,594.00MM | $37,618.00MM |
| Operating Income | $1,056.00MM | $3,757.00MM | $8,193.00MM |
| Non-Operating Income | $-1,321.00MM | $-1,256.00MM | $-1,294.00MM |
| Interest Expense | $1,300.00MM | $1,346.00MM | $1,589.00MM |
| R&D Expense | $9,736.00MM | $9,762.00MM | $11,015.00MM |
| Income(Loss) | $-265.00MM | $2,501.00MM | $6,899.00MM |
| Taxes | $-377.00MM | $-787.00MM | $944.00MM |
| Profit(Loss) | $112.00MM | $3,288.00MM | $5,955.00MM |
| Stockholders Equity | $39,268.00MM | $37,037.00MM | $39,143.00MM |
| Inventory | $8,983.00MM | $4,699.00MM | $5,424.00MM |
| Assets | $105,363.00MM | $96,483.00MM | $101,119.00MM |
| Operating Cash Flow | $5,963.00MM | $9,808.00MM | $10,345.00MM |
| Capital expenditure | $2,200.00MM | $2,571.00MM | $3,778.00MM |
| Investing Cash Flow | $-11,058.00MM | $-2,960.00MM | $-4,064.00MM |
| Financing Cash Flow | $3,649.00MM | $-6,823.00MM | $-6,567.00MM |
| Earnings Per Share* | $0.04 | $1.06 | $1.92 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.